Literature DB >> 29603737

Clinical presentation and magnetic resonance imaging findings in 11 dogs with eosinophilic meningoencephalitis of unknown aetiology.

T J A Cardy1, I Cornelis2.   

Abstract

OBJECTIVES: To describe the clinical presentation, MRI findings and outcome in dogs with eosinophilic meningoencephalitis of unknown origin.
MATERIALS AND METHODS: Dogs were included in this retrospective study if they had complete medical records, complete neurological examination, MR imaging, cerebellomedullary cerebrospinal fluid sample consistent with eosinophilic pleocytosis and negative infectious disease testing.
RESULTS: Eleven dogs were included with a median age of 22·0 months (range 7·6 to 92·0 months). Nine breeds were represented. Neurological abnormalities included obtundation (n=10), menace response deficits (n=9), proprioceptive deficits (n=7), ataxia (n=7) and seizures (n=2). Neuroanatomical localisation was multi-focal (n=4), central vestibular system (n=4), diffuse forebrain (n=2) or left trigeminal/facial nerves (n=1). Seven dogs had peripheral eosinophilia. Ten dogs had bilateral symmetrical lesions affecting the cortical grey matter, which was hyperintense on T2-weighted and fluid-attenuating inversion recovery images and iso- to hypointense on T1-weighted images with associated meningeal contrast enhancement. MRI findings were consistent with diffuse meningitis and atrophy or necrosis of cortical grey matter. One dog had increased contrast uptake in the left trigeminal nerve. Ten dogs receiving corticosteroids survived to discharge, with seven also receiving cytarabine arabinoside. Median survival time was 762 days. CLINICAL SIGNIFICANCE: Eosinophilic meningoencephalitis of unknown origin affects younger larger-breed dogs, with the majority having suspected diffuse cerebrocortical meningitis and cortical (polio)encephalitis, which can be identified on MRI. Response to immunosuppressive treatment is good in the medium to long term, although further studies are required in this area.
© 2018 British Small Animal Veterinary Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29603737     DOI: 10.1111/jsap.12837

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  4 in total

Review 1.  Immune-Mediated Central Nervous System Disease-Current Knowledge and Recommendations.

Authors:  Samantha Vitale; Kari Foss
Journal:  Top Companion Anim Med       Date:  2018-12-04

2.  Inflammatory Disease Affecting the Central Nervous System in Dogs: A Retrospective Study in England (2010-2019).

Authors:  Rita Gonçalves; Steven De Decker; Gemma Walmsley; Sarah Butterfield; Thomas W Maddox
Journal:  Front Vet Sci       Date:  2022-01-27

3.  Screening for Viral Nucleic Acids in the Cerebrospinal Fluid of Dogs With Central Nervous System Inflammation.

Authors:  Renee M Barber; Qiang Li; Jonathan M Levine; Susan J Ruone; Gwendolyn J Levine; Patrick Kenny; Suxiang Tong; Scott J Schatzberg
Journal:  Front Vet Sci       Date:  2022-03-24

4.  Presence of cerebrospinal fluid antibodies associated with autoimmune encephalitis of humans in dogs with neurologic disease.

Authors:  Emma G Stafford; Amanda Kortum; Aude Castel; Lauren Green; Jeanie Lau; Peter J Early; Karen R Muñana; Christopher L Mariani; Jeffrey A Yoder; Natasha J Olby
Journal:  J Vet Intern Med       Date:  2019-09-08       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.